PALMIERI, MARIA
 Distribuzione geografica
Continente #
EU - Europa 3.772
NA - Nord America 3.321
AS - Asia 1.822
SA - Sud America 328
AF - Africa 131
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.392
Nazione #
US - Stati Uniti d'America 3.235
IT - Italia 1.060
RU - Federazione Russa 974
SG - Singapore 555
CN - Cina 433
IE - Irlanda 384
DE - Germania 330
BR - Brasile 288
GB - Regno Unito 276
VN - Vietnam 271
HK - Hong Kong 192
FR - Francia 167
FI - Finlandia 163
SE - Svezia 151
NL - Olanda 86
IN - India 81
KR - Corea 77
ZA - Sudafrica 54
CA - Canada 50
BD - Bangladesh 46
ES - Italia 36
PL - Polonia 26
CI - Costa d'Avorio 23
JP - Giappone 21
MX - Messico 20
UA - Ucraina 20
AT - Austria 19
TR - Turchia 19
IR - Iran 17
CZ - Repubblica Ceca 16
IQ - Iraq 16
AR - Argentina 15
NG - Nigeria 15
CH - Svizzera 13
UZ - Uzbekistan 13
AU - Australia 11
ID - Indonesia 10
PK - Pakistan 10
SA - Arabia Saudita 10
KE - Kenya 9
EG - Egitto 7
BG - Bulgaria 6
MA - Marocco 6
MY - Malesia 6
PH - Filippine 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
BW - Botswana 5
CL - Cile 5
CO - Colombia 5
EC - Ecuador 5
EE - Estonia 5
PT - Portogallo 5
RO - Romania 5
CY - Cipro 4
ET - Etiopia 4
EU - Europa 4
HR - Croazia 4
JM - Giamaica 4
MK - Macedonia 4
SY - Repubblica araba siriana 4
AZ - Azerbaigian 3
BE - Belgio 3
HU - Ungheria 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
LT - Lituania 3
LV - Lettonia 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
CR - Costa Rica 2
GR - Grecia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
FJ - Figi 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
IM - Isola di Man 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
NR - Nauru 1
Totale 9.384
Città #
Dallas 993
Dublin 373
Singapore 366
Moscow 314
Ashburn 278
San Jose 202
Munich 199
Southend 187
Hong Kong 180
Santa Clara 174
Milan 166
Chandler 165
Siena 158
Hefei 115
Helsinki 111
Los Angeles 103
Council Bluffs 97
Beijing 90
Fairfield 81
Rome 77
New York 75
Seoul 75
Ho Chi Minh City 72
Lauterbourg 61
Florence 56
Hanoi 52
Johannesburg 52
Dong Ket 50
Ann Arbor 39
Princeton 39
Houston 33
The Dalles 32
Cambridge 31
São Paulo 31
Turku 30
Seattle 29
Woodbridge 28
Wilmington 27
Abidjan 23
Orem 23
Buffalo 22
London 22
Nuremberg 21
Shanghai 21
Warsaw 21
Bengaluru 19
Chicago 19
Frankfurt am Main 18
Washington 18
Boardman 17
Düsseldorf 17
Tokyo 17
Amsterdam 16
Fremont 16
Montreal 16
Málaga 16
Toronto 16
Redondo Beach 15
Abuja 14
Boston 14
Brescia 14
Chennai 14
Da Nang 14
Lappeenranta 14
Rio de Janeiro 14
Stockholm 14
San Diego 13
Atlanta 12
Bologna 12
Brooklyn 12
Denver 12
Hyderabad 12
Naples 12
Tashkent 12
Aachen 11
City of London 11
Phoenix 11
Portsmouth 11
San Mateo 11
Guangzhou 10
Vienna 10
Zurich 10
Haiphong 9
Mexico City 9
Ankara 8
Carrara 8
Newark 8
Paris 8
Perugia 8
Sydney 8
Baghdad 7
Jacksonville 7
Monte Compatri 7
Mumbai 7
Olomouc 7
Piscataway 7
Poplar 7
Redwood City 7
San Francisco 7
Anagni 6
Totale 6.043
Nome #
A first update on mapping the human genetic architecture of COVID-19 582
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 577
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 504
Genetic mechanisms of critical illness in COVID-19 430
An explainable model of host genetic interactions linked to COVID-19 severity 371
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 356
null 320
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 314
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 302
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 285
CfDNA-NGS Liquid Biopsy for solid cancers and vascular malformations 274
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 258
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients 255
Commentary: Potential links between hepadnavirus and bornavirus sequences in the host genome and cancer 249
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 237
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality 233
A pilot study of next generation sequencing–liquid biopsy on cell-free DNA as a novel non-invasive diagnostic tool for Klippel–Trenaunay syndrome 208
RB1 Germline Variant Predisposing to a Rare Ovarian Germ Cell Tumor: A Case Report 206
WES profiling of COVID-19 205
Differential gene expression analysis pipelines and bioinformatic tools for the identification of specific biomarkers: A review 200
The Personalized Inherited Signature Predisposing to Non-Small-Cell Lung Cancer in Non-Smokers 198
Clinical and molecular characterization of COVID-19 hospitalized patients 194
Cell-free DNA next-generation sequencing liquid biopsy as a new revolutionary approach for arteriovenous malformation 193
Protective role of a TMPRSS2 variant on severe COVID-19 outcome in young males and elderly women 191
Case report: PIK3CA somatic mutation leading to Klippel Trenaunay Syndrome and multiple tumors 183
SELP Asp603Asn and severe thrombosis in COVID-19 males 172
Private somatic mutations identified with liquid biopsy lead tumor progression in solid cancers 170
MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy 164
Nosological and Theranostic Approach to Vascular Malformation through cfDNA NGS Liquid Biopsy 159
Corrigendum: Exome Sequencing in BRCA1-2 Candidate Familias: The Contribution of Other Cancer Susceptibility Genes (Front. Oncol., (2021), 11, 10.3389/fonc.2021.649435) 156
Correction: SELP Asp603Asn and severe thrombosis in COVID-19 males 153
Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era 149
PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis 147
Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: a systematic review and meta-analysis 136
Specific clonal expansion at disease progression (PD) in solid cancers pinpointed by cell free DNA analysis 122
The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions 121
Editorial: Liquid biopsy and new omics technologies in vascular malformations 119
Editorial: Lung adenocarcinoma: from genomics to immunotherapy 99
The Evidence Base for Circulating Tumor DNA-Methylation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis 96
Editorial: Recent advancements in RNA-based and targeted therapeutics 72
Editorial: Unveiling the potential of CTCs in drug resistance mechanisms and personalized medicine 69
From asbestos exposure to carcinogenesis: Transcriptomic signatures in malignant pleural mesothelioma 61
Liquid Biopsies 48
Noninvasive Genetic Testing: Adhesive Patch-Based Skin Biopsy and Buccal Swab 46
Longitudinal Whole-Exome Sequencing of Cell-Free DNA Reveals Molecular Evolution and Heterogeneous Clinical Outcomes in PD-L1 Stratified Advanced NSCLC Adenocarcinoma Patients Treated with Atezolizumab 12
Mapping the human genetic architecture of COVID-19 12
Totale 9.608
Categoria #
all - tutte 31.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.038


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202185 0 0 0 0 0 0 0 0 0 0 0 85
2021/2022578 68 48 36 48 38 32 31 32 29 31 68 117
2022/2023773 46 75 75 76 50 185 79 70 38 23 29 27
2023/2024786 27 28 101 45 30 177 217 45 9 26 25 56
2024/20252.001 62 63 193 137 220 158 191 147 181 100 194 355
2025/20264.976 295 671 792 670 897 221 565 163 205 268 147 82
Totale 9.608